FSPHX Mutual Fund

NAV$27.90
Showing 10 of 134 holdings(as of Feb 28, 2026)Top 10 Weight: 43.29%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1LLYEli Lilly & Co6.93%408,000$429.21M••••••••••••••••••••••
2DHRDanaher Corp.6.39%1,880,000$396.00M••••••••••••••••••••••
3BSXBoston Scientific Corp6.01%4,850,000$372.72M••••••••••••••••••••••
4JNJJohnson & Johnson5.61%1,400,000$347.80M••••••••••••••••••••••
5ABBVAbbvie Inc4.27%1,140,000$264.57M••••••••••••••••••••••
6NMFFidelity Securities Lending Cash Central Fund3.62%224,531,147$224.55M••••••••••••••••••••••
7ASND:COAscendis Pharma As Adr2.70%716,000$167.19M••••••••••••••••••••••
8GILDGilead Sciences Inc2.60%1,080,000$160.87M••••••••••••••••••••••
9UCB:BRUcb Sa2.60%540,000$160.98M••••••••••••••••••••••
10MRKMerck & Company Inc2.56%1,280,000$158.49M••••••••••••••••••••••
Want to see all 134 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyFood InnovationHealth & WellnessMedical DevicesCardiologyDigital HealthImmunologyOncologyUrbanizationInflation ProtectionSocial ImpactInfrastructureLife Sciences ToolsSemiconductors

FSPHX Mutual Fund Top Holdings

FSPHX holdings top 10 positions. The top 10 holdings account for 43.3% of the fund, led by Eli Lilly & Co at 6.9%, Danaher Corp. at 6.4%, Boston Scientific Corp at 6.0%.

FSPHX portfolio concentration is moderate, with the top 10 representing 43.3% of total assets. The largest sector exposure is Health Care at 87.8%.

FSPHX sector allocation provides a detailed breakdown. FSPHX overlap tool shows how holdings compare to other funds in your portfolio.